InVivoMAb anti-human PD-1 (CD279)
1/2

InVivoMAb anti-human PD-1 (CD279)

分享
品牌: BioXcell
pdf 下载产品说明书
pdf 下载SDS
用小程序,查商品更便捷
收藏
对比对比
咨询咨询
    反应种属:
    human
    human
    产品介绍
    产品信息
    克隆号
    J116
    克隆类别
    单抗

    Product Details

    The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily. PD-1 is transiently expressed on CD4 and CD8 thymocytes as well as activated T and B lymphocytes and myeloid cells. PD-1 expression declines after successful elimination of antigen. Additionally, Pdcd1 mRNA is expressed in developing B lymphocytes during the pro-B-cell stage. PD-1’s structure includes a ITIM (immunoreceptor tyrosine-based inhibitory motif) suggesting that PD-1 negatively regulates TCR signals. PD-1 signals via binding its two ligands, PD-L1 and PD-L2 both members of the B7 family. Upon ligand binding, PD-1 signaling inhibits T-cell activation, leading to reduced proliferation, cytokine production, and T cell death. Additionally, PD-1 is known to play key roles in peripheral tolerance and prevention of autoimmune disease in mice as PD-1 knockout animals show dilated cardiomyopathy, splenomegaly, and loss of peripheral tolerance. Induced PD-L1 expression is common in many tumors including squamous cell carcinoma, colon adenocarcinoma, and breast adenocarcinoma. PD-L1 overexpression results in increased resistance of tumor cells to CD8 T cell mediated lysis. In mouse models of melanoma, tumor growth can be transiently arrested via treatment with antibodies which block the interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being explored as cancer treatments. Binding of the J116 antibody is reported to inhibit PD-1 signal transduction, however, it is not reported to block PD-L1 binding.

    Specifications

    Isotype Mouse IgG1, κ
    Recommended Isotype Control(s)InVivoMAb mouse IgG1 isotype control, unknown specificity
    Recommended Dilution BufferInVivoPure pH 7.0 Dilution Buffer
    Conjugation This product is unconjugated. Conjugation is available via our Antibody Conjugation Services.
    Immunogen Not available or unknown
    Reported Applicationsin vitro PD-1 neutralization
    in vivo PD-1 blockade in humanized mice
    Formulation PBS, pH 7.0
    Contains no stabilizers or preservatives
    Endotoxin <2EU/mg (<0.002EU/μg)
    Determined by LAL gel clotting assay
    Purity >95%
    Determined by SDS-PAGE
    Sterility 0.2 µm filtration
    Production Purified from cell culture supernatant in an animal-free facility
    Purification Protein G
    RRIDAB_10950318
    Molecular Weight 150 kDa
    Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
    组成成分
    程序性死亡蛋白抗体,磷酸盐缓冲液
    应用
    反应种属
    human
    背景
    别名
    PD-1,PD1,CD279,hPD-1,PDCD1,Programmed cell death protein 1
    研究领域
    Cancer Biology, Immune Checkpoint Protein, Immunology
    声明 :本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。
    货号:
    BE0188-50MG
    一键复制
    询价
    1mg
    5mg
    25mg
    50mg
    100mg
    选择数量
    当前规格1件起购 
    配送至
    预计2-3周送达,快递: 免运费,若需干冰额外收费